Suven Life Sciences Ltd (SUVEN)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 221.70
% Change: -5.00% (Prev Close: 233.36)

Volume: 2,33,049
% Change: 305.66% (Prev Volume: 57,449)

Delivery: 1,75,440
Delivery % : 75.28
% Change: 0.00% (Prev Delivery: 0)

Turnover: 525 Lacs
% Change: 296.96% (Prev Turnover: 132)

πŸ’Ή EOD Valuation

P/E Ratio: 0.00
P/B Ratio: 43.99
Market Cap: 5039 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: SUVEN
Market Cap: 4862 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 303.00
52 Week Low: 102.50

All-Time High: 303.00 Rs.
All-Time Low: 0.59 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-19.65% | -2.63% | 70.83% | 46.87% | 49.12%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 67.43%

Change (3Y | 1Y): 2.45% | -2.84%

Pledged %: 0.00%

FII Holding

FII Holding: 0.56%

Change (3Y | 1Y): 0.11% | 0.31%

DII Holding

DII Holding: 3.41%

Change (3Y | 1Y): 3.02% | 3.40%

Public Holding: 28.61%

🏦 Financial Strength

Debt to Equity: 0.00
Debt: 0.00 Rs. Cr.

Book Value: 5.04 Rs.
Current Ratio: 2.26
Interest Coverage: -6140.00
Free Cash Flow: -191.38 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: -15.60%

Sales Growth Qtr (YOY | QoQ):
85.15% | 27.21%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-12.00% | -17.45% | -15.60%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: -58.16%

Profit Growth Qtr (YOY | QoQ):
-83.74% | -17.25%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-24.19% | -11.87% | -58.16%

EPS Rs.

EPS (TTM): -8.45 Rs.

EPS Qtr (Last Year | Latest):
-1.29 Rs. | -2.36 Rs.

EPS Annual (Last Annual | Annual March):
-4.82 Rs. | -7.37 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-14.08% | -11.87%

Net Profit Rs. Cr.

Net Profit (TTM): -184.22 Rs. Cr.

Net Profit (Annual - March): -160.75 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
-28.04| -43.94 | -51.52

EBITDA Rs. Cr.

EBITDA (Quarter): -50.15 Rs. Cr.
EBITDA (Previous Yr Ql): -26.53 Rs. Cr.

EBITDA (Annual - March): -159.73 Rs. Cr.
EBITDA (Previous Annual): -111.29 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
-15.27% | -12.10%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): -2473.14%

OPM Qtr (Previous | Current):
-2980.95% | -2713.90%

OPM Annual (5 Yrs | Last Yr | March):
-1086.16% | -1093.84% | -2487.24%

Return on Equity %

ROE: -87.22%

ROE (5 Yrs | 3 Yrs | Last Yr):
-62.19% | -54.63% | -36.29%

Return on Capital Employed %

ROCE: -86.96%

ROCE (5 Yrs | 3 Yrs | Last Yr):
-70.54% | -58.70% | -36.37%

Return on Assets %

ROA (TTM): -78.90%

ROA (5 Yrs | 3 Yrs | Last Yr):
-63.50% | -54.80% | -34.75%

PEG Ratio: 0.00
Dividend Yield: 0.00%

PE 3 Yrs: 0.00
PE 5 Yrs: 0.00

Dividend Yield: 0.00%

πŸ‘₯ Company

Suven Life Sciences Ltd

SUVEN

Promoter Holding: %